Close

News

3 Cancer Types Which May Be Caused By External Sources

Cancer is a complex disease with many different factors contributing to its growth in the body. Due to the vast types of cancer, many companies are setting up trials on different medications to see if it can help people...

Uncovering the Truth About Breast Cancer Risk Factors

Breast cancer remains one of the most prevalent cancers among women globally, affecting millions and reshaping lives. The key to combating this disease lies not only in effective treatments but also in a comprehensive understanding of its risk factors....

RoukenBio completes phase 2 discovery centre expansion and unveils new brand identity

RoukenBio, the Collaborative Research Organisation (CRO) formerly known as Antibody Analytics, has today announced completion of the phase 2 expansion of its Discovery Centre in Motherwell, Scotland. In addition to this key business milestone, the immunology CRO has unveiled its...

OneSource, a multimodal global specialty pharma CDMO launches at CPHI Milan

CDMO anticipates sales of $400M by 2028 OneSource Specialty Pharma, a newly incorporated CDMO, formed from the merger of three CDMO businesses within the Strides Group launches at CPHI Milan. The company has a 30-year track-record of excellence in manufacturing...

The Impact of Long-Term Use of Sleeping Pills on Mental and Physical Health

Understanding the effects of long-term use of sleeping pills is crucial for anyone considering or currently using them for sleep management. These medications often seem like a straightforward solution to persistent sleep issues, but their prolonged use can lead...

At Pack Expo, Schreiner MediPharm to Showcase New RFID Labels with Digital Seal Function

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will showcase its new RFID label with digital first-opening indication at Pack Expo 2024, November 3-6 in Chicago. The new solution – which irreversibly...

Phesi launches Investigator Site Profile solution, enabling sponsors to eliminate non-active, non-enrolling trial sites

Phesi, a leading clinical development analytics company, has launched a self-service Investigator Site Profile solution designed to eliminate the non-active and non-enrolling investigator sites that development programs are typically burdened with. Investigator Site Profile leverages data from Phesi’s award-winning...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read